EcoR1 Capital, Director: Zymeworks ZYME Buy · Filed 24/12/26

Trade details

Type: Insider buy
Amount: $9,919,191.04
Shares · price: 704,488 sh · $14.08 a share
Held after: 14,440,779 sh
Stock: Zymeworks ZYME
Person: EcoR1 CapitalDirector
Trade date: 24/12/20
Filed: 24/12/26
Days to filing: 6 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +5.1%

Zymeworks trades, last 26 weeks

What else happened in Zymeworks around then

Filed or reported within 30 days of the trade day · 24/11/20~25/01/19

EcoR1 Capital's recent trades

EcoR1 Capital10% Owner
BuyAtara Biotherapeutics
Buy
Atara Biotherapeutics
ATRA
$4.7M
507,407 sh
$4.7M
Filed 05/11
Traded 05/07
EcoR1 Capital10% Owner
SellFirst Tracks Biotherapeutics
Sell
First Tracks Biotherapeutics
TRAX
$65M
4,705,575 sh
$65M
Filed 04/22
Traded 04/20
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3.7M
33,931,740 sh
$3.7M
Filed 25/07/30
Traded 25/07/28
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2.7M
27,433,338 sh
$2.7M
Filed 25/07/30
Traded 25/07/30
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$268.7K
2,687,460 sh
$268.7K
Filed 25/07/30
Traded 25/07/29